ipamorelin dosage Cycle Guide: Optimal Dosage, Timing, and Best Peptide Stack Ipamorelin: Benefits, Dosage & Risks

PMID: 19289567 Wideman L, Weltman JY, Patrie JT, Bowers CY, Shah N, Story S, et al

UniProt ID: P00552) and the gene for aminoglycoside/streptomycin adenylyltransferase (AadA1) from Tn21 ( str r

The findings established Ipamorelin's defining characteristic: Growth hormone Ipamorelin produced dose-dependent GH release comparable to GHRP-6 Cortisol No significant cortisol elevation was observed with Ipamorelin, while GHRP-2 and GHRP-6 produced measurable cortisol increases Prolactin No significant prolactin elevation at GH-effective concentrations ACTH No significant ACTH stimulation, contrasting with the adrenocorticotropic effects of other GHRPs GHRP Selectivity Comparison (Preclinical Data) Compound GH Release Cortisol Effect Prolactin Effect ACTH Effect Ipamorelin Dose-dependent Minimal / none Minimal / none Minimal / none GHRP-2 Dose-dependent Moderate increase Moderate increase Moderate increase GHRP-6 Dose-dependent Moderate increase Moderate increase Moderate increase Hexarelin Strong Significant increase Significant increase Significant increase Data adapted from Raun et al

The reason for this disagreement could be that the set of genes involved in the uptake and metabolism of these sugars are incomplete, or these were false negatives and should be confirmed with a conventional phenol red broth or other more sensitive methods